Thomas George Munyon

Thomas Munyon practices at Pacific Dermatology Institute in Palm Desert, California.

Thomas Munyon's NPI, 1568481588, was assigned on July 19, 2006. Thomas Munyon graduated from Carver College of Medicine in 1975. Thomas Munyon holds California license A30666.

Thomas Munyon's primary practice is Pacific Dermatology Institute, at 74090 El Paseo, Palm Desert, CA 92260 in Riverside County. The practice phone is (951) 734-8989.

Thomas Munyon's primary practice is Pacific Dermatology Institute in Palm Desert, California. The medical group on file is Pacific Dermatology Institute. Dmand AI also links Thomas Munyon to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Thomas Munyon practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Thomas Munyon's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Thomas Munyon is board certified in dermatology by the American Board of Dermatology. Thomas Munyon is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Thomas Munyon treats.

CMS data shows 1,507 Medicare services from Thomas Munyon across 14 procedure codes in 2024, for 305 Medicare patients. Medicare paid $59,454 for them. Every service was in an office.

CMS counts 305 Medicare patients who saw Thomas Munyon in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Thomas Munyon's median patient age at 60, with 57% women.

In 2024, Thomas Munyon wrote 2,425 Medicare Part D claims for 701 patients. 94% of them were for generic drugs. CMS names the drug for 2,246 of them, across 41 drugs with 11 or more claims each, at $342,735 in total drug cost. In 2023, CMS named 1,834 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Thomas Munyon for performance year 2024, reported individually. Thomas Munyon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 524 procedures of removal of skin lesions by Thomas Munyon, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Thomas Munyon. Thomas Munyon's most frequent co-authors are Doris J. Day, MD and Francis Rogers Palmer, MD.

Dmand AI links Thomas Munyon to 1 clinical trial. Conditions studied include Melanoma and Nevi and Melanomas.

CMS Open Payments shows 148 general payments to Thomas Munyon from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Galderma Laboratories, L.P. paid the most, $677.

Thomas Munyon graduated from Carver College of Medicine in 1975.

Thomas Munyon is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.